| Advanced Enzyme Technologies Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540025 |
NSE Symbol : ADVENZYMES |
P/E(TTM) : 36.29 |
|
ISIN Demat : INE837H01020 |
Div & Yield% : 1.99 |
EPS(TTM) : 7.40 |
|
Book Value(₹) : 63.35 |
Market Cap(₹Cr) : 3,007.12 |
Face Value(₹) : 2.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 115.86 | 116.41 | 95.58 | 115.75 | 125.02 | 87.21 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 115.86 | 116.41 | 95.58 | 115.75 | 125.02 | 87.21 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.29 | 5.16 | 1.29 | 3.08 | 53.85 | 4.53 |
| Total Income | 118.14 | 121.57 | 96.88 | 118.83 | 178.88 | 91.74 |
| Total Expenditure | 85.45 | 89.56 | 75.98 | 86.16 | 94.50 | 73.04 |
| PBIDT | 32.70 | 32.02 | 20.90 | 32.67 | 84.38 | 18.70 |
| Interest | 0.04 | 0.06 | 0.05 | 0.05 | 0.05 | 0.08 |
| PBDT | 32.66 | 31.96 | 20.85 | 32.62 | 84.33 | 18.62 |
| Depreciation | 2.92 | 3.12 | 3.04 | 3.00 | 2.93 | 3.11 |
| Tax | 6.66 | 6.77 | 5.58 | 7.28 | 7.44 | 3.55 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.73 | -0.22 | -1.01 | 0.05 | -0.03 | 0.91 |
| Reported Profit After Tax | 22.35 | 22.30 | 13.25 | 22.28 | 73.98 | 11.05 |
| Extra-ordinary Items | 0.00 | 0.00 | -2.65 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 22.35 | 22.30 | 15.90 | 22.28 | 73.98 | 11.05 |
| EPS (Unit Curr.) | 2.00 | 1.99 | 1.18 | 1.99 | 6.61 | 0.99 |
| EPS (Adj) (Unit Curr.) | 2.00 | 1.99 | 1.18 | 1.99 | 6.61 | 0.99 |
| Calculated EPS (Unit Curr.) | 2.00 | 1.99 | 1.18 | 1.99 | 6.61 | 0.99 |
| Calculated EPS (Adj) (Unit Curr.) | 2.00 | 1.99 | 1.18 | 1.99 | 6.61 | 0.99 |
| Calculated EPS (Ann.) (Unit Curr.) | 7.98 | 7.97 | 4.73 | 7.97 | 26.45 | 3.95 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 7.98 | 7.97 | 4.73 | 7.97 | 26.45 | 3.95 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 22.40 | 22.39 | 22.39 | 22.38 | 22.38 | 22.38 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 28.22 | 27.51 | 21.87 | 28.22 | 67.49 | 21.44 |
| PBDTM(%) | 28.19 | 27.45 | 21.81 | 28.18 | 67.45 | 21.35 |
| PATM(%) | 19.29 | 19.16 | 13.86 | 19.25 | 59.17 | 12.67 |
